0
0
Published December 1, 2025
SALT LAKE CITY — For decades, suicide prevention has relied heavily on a single, powerful premise: that identifying and treating mental health conditions like depression is the key to saving lives. But a groundbreaking new study from the University of Utah Health has uncovered a startling biological reality that challenges this convention. According to research published this week in JAMA Network Open, approximately half of all individuals who die by suicide show no previous warning signs—not because their mental illness went undiagnosed, but because they possess a completely distinct genetic and biological profile.
The findings offer a scientific explanation for the agonizing refrain often heard from grieving families: “We had no idea.” They also suggest that the current “one-size-fits-all” approach to screening, which primarily targets depression and anxiety, may be failing a massive segment of the at-risk population.
The “Silent” Cohort
The study, led by Hilary Coon, PhD, a professor of psychiatry at the Spencer Fox Eccles School of Medicine, analyzed anonymized genetic data from more than 2,700 individuals who died by suicide. The research team sought to understand a baffling phenomenon: roughly 50% of suicide decedents have no documented history of mental illness, no prior suicide attempts, and no known suicidal thoughts.
For years, the medical community assumed these individuals were simply “flying under the radar”—suffering from undiagnosed depression or anxiety that was missed by clinicians.
“Researchers had speculated that people without known suicidality might still experience similar levels of depression or anxiety, only without formal diagnosis,” Dr. Coon explained.
But the genetic data told a different story.
A Surprising Biological Distinction
Using Polygenic Risk Scores (PRS)—a method that estimates an individual’s genetic likelihood for developing specific traits—the researchers compared the “no-warning” group to those with documented histories of distress.
The results were unexpected. The individuals who died without warning did not carry the high genetic burden for depression, anxiety, or schizophrenia typically seen in suicidal behavior. In fact, their genetic risk for these conditions was significantly lower, comparable to the general population.
“There are a lot of people out there who may be at risk of suicide where it’s not just that you’ve missed that they’re depressed; it’s likely that they’re in fact actually not depressed,” said Dr. Coon. “That is important in widening our view of who may be at risk.”
This suggests that for this subgroup, suicide is not the fatal endpoint of a long battle with mental illness, but potentially the result of a different, rapid-onset biological pathway that standard screenings are not designed to detect.
Beyond Depression: The Search for New Markers
If not depression, what is driving the risk in this “silent” group?
While the current study definitively rules out “hidden” psychiatric genetic risk, it opens the door to other biological culprits. Dr. Coon’s team is now pivoting to investigate physical health factors that may act as invisible triggers. Preliminary hypotheses point to inflammation, respiratory conditions, and chronic pain as potential drivers that could destabilize individuals who are otherwise mentally healthy.
This aligns with a growing body of research linking metabolic and immune system dysfunction to behavioral changes. Dr. Robert Naviaux, a professor at the University of California, San Diego, who was not involved in the Utah study, has previously identified metabolic markers in the blood that correlate with suicidal ideation, suggesting that cellular health plays a critical role in mental state.
“We need to start to think about aspects leading to risk in different ways,” Coon emphasized. If a person’s risk is driven by physiological stress—such as systemic inflammation—rather than psychological distress, asking them “Do you feel sad?” may yield a “No,” even as they approach a crisis point.
Implications for Public Health
The implications of these findings are profound for healthcare providers and public health policy. Standard suicide risk assessments, such as the PHQ-9 depression questionnaire used in primary care clinics, are excellent for catching the 50% of cases related to mood disorders. However, they are likely failing the other 50%.
“A tenet in suicide prevention has been that we just need to screen people better for associated conditions like depression,” Coon noted. “But for those who actually have different underlying vulnerabilities, increasing that screening might not help for them.”
This research suggests a need for a dual-track approach: continuing to screen for mental illness while developing new biomarkers—perhaps blood tests or physical health screenings—that can flag “silent” risk factors like high inflammatory loads or specific genetic vulnerabilities unrelated to mood.
Limitations and Context
While the study provides a crucial missing piece of the puzzle, experts urge caution in interpretation. Genetic risk factors are probabilistic, not deterministic; there is no single “suicide gene.” Environmental factors—such as financial crisis, relationship breakdown, or access to lethal means—remain critical triggers, particularly for those who may be biologically vulnerable to acute stress but not chronically depressed.
Furthermore, the research is currently retrospective. Transforming these genetic and biological insights into a predictive clinical tool will require years of further validation.
A New Path Forward
For families left behind by “silent” suicides, this research offers a painful but necessary validation: the signs weren’t missed because no one was looking, but because the science of what to look for hadn’t yet been written. By acknowledging that suicide can stem from biological pathways distinct from mental illness, the medical community can begin to build a safety net that truly covers everyone.
Medical Disclaimer:
This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges. If you or someone you know is in crisis, please call or text 988 (in the U.S.) or contact your local emergency services immediately.
References
-
Primary Study: Coon, H., et al. (2025). “Genetic Liabilities to Neuropsychiatric Conditions in Suicide Deaths With No Prior Suicidality.” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2025.38204
